B-type natriuretic peptide (BNP) antibody and antigen (Recombinant protein)

Diagnostic B-type natriuretic peptide (BNP) antibodies (anti-B-type natriuretic peptide, anti-BNP) and antigens (recombinant B-type natriuretic peptide (BNP) protein) for Cardiovascular disease BNP detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Cardiovascular disease diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-BNP-Ag01 Recombinant human BNP Protein $3090.00
GMP-h-BNP-Ab01 Anti-human BNP mouse monoclonal antibody (mAb) $1953.00
GMP-h-BNP-Ab02 Anti-human BNP mouse monoclonal antibody (mAb) $1953.00
GMP-h-BNP-Ab03 Anti-human BNP human monoclonal antibody (mAb) $1953.00
GMP-h-BNP-Ab04 Anti-human BNP human monoclonal antibody (mAb) $1953.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Pruducts GMP-h-BNP-Ag01
Product Name Recombinant human BNP Protein
Target/Biomarker B-type natriuretic peptide (BNP)
Alias of Target/Biomarker BNP, Iso-ANP
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation
Products description Recombinant Human B-type natriuretic peptide (BNP) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts GMP-h-BNP-Ab01,GMP-h-BNP-Ab02
Product Name Anti-human BNP mouse monoclonal antibody (mAb)
Target/Biomarker B-type natriuretic peptide (BNP)
Alias of Target/Biomarker BNP, Iso-ANP
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human B-type natriuretic peptide (BNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation.
Tag mFc
Products description Anti-human BNP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. of Pruducts GMP-h-BNP-Ab03,GMP-h-BNP-Ab04
Product Name Anti-human BNP human monoclonal antibody (mAb)
Target/Biomarker B-type natriuretic peptide (BNP)
Alias of Target/Biomarker BNP, Iso-ANP
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Human B-type natriuretic peptide (BNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation.
Tag hFc
Products description Anti-human BNP mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    BNP) in response to increased mechanical load and wall stretch. BNP protects the heart from adverse consequences of overload by increasing natriuresis and diuresis, relaxing vascular smooth muscle, inhibiting the renin-angiotensin-aldosterone system, and by counteracting cardiac hypertrophy and fibrosis. BNP is synthesized by human cardiac myocytes as a 108-amino acid prohormone (proBNP), which is cleaved to the 32-residue BNP and the 76-residue N-terminal fragment of proBNP (NT-proBNP). Both can be used as sensitive biomarkers of cardiac dysfunction and well-characterized commercial assays have recently become available. In acute coronary syndromes increased concentrations are strong predictors of recurring myocardial infarction, heart failure, and death. In acute dyspnea, high BNP and NT-proBNP point to a cardiac rather than a pulmonary origin of the symptoms. BNP and NT-proBNP help in the assessment of the severity of ventricular dysfunction and heart failure and as a prognostic predictor, regardless of the primary cause of the condition.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment